Acrysof(R) and Polymethylmethacrylate Intraocular Lens Implantation in Diabetic Patients.
- Author:
Jin Seob LIM
1
;
Kun Jin YANG
;
Yeoung Geol PARK
Author Information
1. Department of Ophthalmology, Chonnam University Medical School & Hospital Kwangju, Korea. kjyang@chonnam.ac.kr
- Publication Type:Original Article
- Keywords:
Acrysof;
Cataract;
Diabetes mellites;
PMMA;
Posterior capsular opacification
- MeSH:
Cataract;
Cataract Extraction;
Diabetic Retinopathy;
Follow-Up Studies;
Humans;
Jeollanam-do;
Lens Implantation, Intraocular*;
Lenses, Intraocular*;
Medical Records;
Polymethyl Methacrylate*;
Postoperative Complications;
Retrospective Studies;
Visual Acuity
- From:Journal of the Korean Ophthalmological Society
2002;43(3):464-470
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: To determine the efficacy of Acrysof(R) intraocular lens (IOL) compared to PMMA IOL about visual acuity & postoperative complications (eg. posterior capsular opacification) in diabetic patients. PATIENTS AND METHODS: We retrospectively reviewed the medical records of 18 patients (21 eyes) which underwent cataract extraction with Acrysof (R) IOL implantation and 58 patients (65 eyes) with PMMA (polymethylmethacrylate) IOL implantation from January 1996 to December 1999 at Chonnam National University Hospital. RESULTS: Postoperative best corrected visual acuity of above or equal to 0.5 was seem in 66.7% in acrysof (R) group, and in 73.9% in PMMA group at 6 months follow-up. Postoperative posterior capsular opacification was 33.3% and 49.2% respectively, and there was statistically significant difference in both group(p=0.021). CONCLUSIONS: Acrysof(R) intraocular lens can be used safely and reduce the rate of posterior capsular opacification in diabetic patients, which can make the positive effect on the treatment of the diabetic retinopathy after cataract surgery.
